featured
Upadacitinib for the Treatment of Active Non-Radiographic Axial Spondyloarthritis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet 2022 Jul 30;400(10349)369-379, A Deodhar, F Van den Bosch, D Poddubnyy, WP Maksymowych, D van der Heijde, TH Kim, M Kishimoto, R Blanco, Y Duan, Y Li, AL Pangan, P Wung, IH SongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.